If the sum of the incidence of the various types of diseases prevented by the vaccine is used as the end point of the clinical trial, the trial should be of a considerable scale, that is, the serotype with low incidence should be ensured that there are still data for a certain number of people. To evaluate its effectiveness.
正在翻译中..